Intelligence · Patents
Patents expiring in 2035
Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.
- Patents
- 1,447
Quick answer
1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9023795
Angiogenesis-inhibiting peptide and application thereof
granted -
US 9024069
NONOate derivatives and uses thereof
granted -
US 9023798
Cystinosin replacement factor
granted -
US 9023984
Diagnostic and therapeutic target for autoimmune diseases and uses thereof
granted -
US 9023322
Chewing gum compositions comprising cannabinoids
granted -
US 9023340
Wnt inhibitors for human stem cell differentiation
granted -
US 9023866
2-selenophene-4-quinolones as anticancer agents
granted -
US 9023867
Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents
granted -
US 9023858
Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors
granted -
US 9023823
Micro-RNA's that regulate muscle cells
granted -
US 9029318
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 9028499
Bone cutting device
granted -
US 9029521
EML4-ALK fusion gene
granted -
US 9028842
Compositions and methods for treatment, research and therapeutic applications for malaria
granted -
US 9029338
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
granted -
US 9028809
Compositions, methods and uses for expression of enterobacterium-associated peptides
granted -
US 9028877
Bioeffective krill oil compositions
granted -
US 9029342
Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
granted -
US 9029502
Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
granted -
US 9029388
Condensed heterocyclic compound
granted -
US 9029326
Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
granted -
US 9029344
Linked purine pterin HPPK inhibitors useful as antibacterial agents
granted -
US 9029509
Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)
granted -
US 9029413
Treatment of viral infections by modulation of host cell metabolic pathways
granted -
US 9029536
Fused heterocyclic compounds
granted -
US 9028841
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 9029550
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
granted -
US 9029530
Detection of oligosaccharides
granted -
US 9029525
Compositions and methods for inhibiting expression of GSK-3 genes
granted -
US 9029557
Labeled A4B2 ligands and methods therefor
granted -
US 9029546
Pyrazolopyridine kinase inhibitors
granted -
US 9029394
2-phenyl-4-quinolones as anticancer agents
granted -
US 9029321
Methods and compositions for targeting adipose cells in mammals
granted -
US 9028887
Method improve spatial memory via pterostilbene administration
granted -
US 9028819
Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2
granted -
EP 2870969
Pharmazeutische Zusammensetzung zur Reduzierung der adipösen Masse
granted -
US 9034311
Pyridin-2(1 H)-one derivatives as JAK inhibitors
granted -
US 9034313
Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
granted -
US 9034829
pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics
granted -
US 9034343
Attenuated human parainfluenza virus, methods and uses thereof
granted -
US 9034336
Immunomodulators and immunomodulator conjugates
granted -
US 9034323
Method for control of post-prandial glucose
granted -
US 9034347
Drug delivery system and method for the treatment of neuro-degenerative disease
granted -
US 9034642
Genes of an otitis media isolate of nontypeable Haemophilus influenzae
granted -
US 9034881
Treatment for vitiligo
granted -
US 9034903
Acyl piperidine inhibitors of soluble epoxide hydrolase
granted -
US 9034923
Methods for the treatment of senile dementia of the alzheimer's type
granted -
US 9035041
Process for triphosphate oligonucleotide synthesis
granted
Frequently asked questions
How many pharma patents expire in 2035?
1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.